Brief: Phoenix Biotech Acquisition Corp. Announces Pricing Of $155,000,000 Initial Public Offering
Oct 5 (Reuters) - Phoenix Biotech Acquisition Corp PBAX.O :
* PHOENIX BIOTECH ACQUISITION CORP. ANNOUNCES PRICING OF
$155,000,000 INITIAL PUBLIC OFFERING
* PHOENIX BIOTECH ACQUISITION CORP - ANNOUNCED PRICING OF
ITS IPO
OF 15.5 MILLION UNITS AT A PRICE OF $10.00 PER UNIT
* PHOENIX BIOTECH ACQUISITION CORP - CO'S UNITS WILL BE
LISTED ON
NASDAQ GLOBAL MARKET UNDER SYMBOL "PBAXU" AND WILL BEGIN TRADING
ON OCT 6, 2021
Source text for Eikon: ID:nGNXb3C0xy
Further company coverage: PBAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CERo Therapeutics Holdings
See all newsBrief: Cero Therapeutics Hearing Review Council Issued Decision
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml (Certaint-1)
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Clinical Trial
Brief: Cero Therapeutics Holdings Inc - Continues To Evaluate Additional Options For Up-List